The senior partner tells the associate over coffee that she has made partner. He means it warmly, he has been carrying the recruiting conversation for a year, and he assumes the rest of the group will be pleased. Two of his partners hear about it from the associate. The agreement says nothing about how partners are admitted, so nothing that happened was technically improper—which is the whole problem. A permanent change to the practice’s ownership, governance, and economics has been set in motion by one conversation nobody voted on.
Admission is the most consequential decision a partnership makes, and it is the one most often handled informally. Every other decision in the agreement can be revisited. This one adds a person with a vote, a claim on distributions, a seat at every future meeting, and a buy-out obligation the practice will carry for decades. Reversibility is the principle that sets voting thresholds, and admission is close to irreversible. It belongs on the reserved-matters catalog at a supermajority of two-thirds to 75 percent, decided at a noticed meeting with the terms in front of every partner in advance.
Two questions come before the vote, and they decide whether the conversation should happen at all. The first is motive. Is this physician committed to the practice’s vision and prepared to carry the risk and the governance work that ownership entails, or is the attraction the money? The distinction matters because the money problem has a cheaper solution. A physician motivated chiefly by earnings can be kept, and kept happy, on a well-designed compensation package, with no vote conveyed, no veto, and no permanent seat at the governance table. Equity should answer commitment; compensation should answer money. Confuse the two and a purely financial actor sits inside every decision the agreement governs.
The second question is the number of partners itself. The most durable answer in pediatric practice management belongs to Chip Hart of the Physician’s Computer Company, and it never changes: the least number possible. Every additional partner multiplies the deadlock surfaces of article 17, the buyout obligations the practice must eventually fund, and the number of people who must agree before anything gets implemented. Add a partner when the practice needs another owner—not because tenure made the question awkward.
Then write the criteria down, because criteria that live in the partners’ heads are not criteria. A defensible set is objective and knowable in advance: a stated associate period of two to three years, board certification, uninterrupted licensure and payer enrollment, a minimum clinical full-time-equivalent commitment, insurability for the practice’s buyout funding, and demonstrated citizenship—committee work, call participation, the unglamorous administrative portfolio somebody has to carry. The sharpest criterion of all gates the offer on recovered investment rather than tenure. The option opens after two to three years and $150,000 to $300,000 of cumulative profit the associate has generated for the practice, with $200,000 the working floor most groups settle on. Time served is the weakest test on the list. Breaking even after 18 months is not a high enough bar for access to ownership, and nobody builds a full panel in a year.
Audit the stated track against the practice’s own history. If the agreement promises two to three years and the last three associates made partner in year five, the recruiting pitch is fiction and the next associate will discover it at exactly the wrong moment. Correct the stated track, or change how the practice promotes.
Price the buy-in by formula rather than by negotiation, and disclose the methodology up front. An associate who cannot learn the price formula until year three is negotiating blind, and practices that publish the methodology recruit measurably better. Whatever methodology prices the way in must price the way out—the symmetry principle, and the one term in the entire structure that should never be traded. Asymmetric methodologies are wealth transfers, and they are always discovered eventually. The mechanics of pricing, financing, and the investment case belong to articles 3 and 4; the governance point here is narrower. The formula exists, it is written down, it is the same for everyone, and it is handed to the candidate with a worked example before anyone asks for a signature.
Define what the equity actually conveys, and define it in phases if that is the design. Voting rights immediately, or after a probationary period of non-voting economics. Distribution participation and its formula. Sale-proceeds participation, which is the variable everyone discovers at the letter of intent, and which article 24 takes up in full. And the continuing obligations that keep the seat: the clinical FTE threshold below which equity is adjusted or repurchased, call participation, credentials maintained, and the management duty an owner owes. An agreement that defines admission and removal while leaving continued membership undefined has documented the two ends of a partnership and left out the middle.
Advanced practice provider eligibility deserves an explicit answer before the question arrives organically, because it will arrive. State corporate-practice and professional-entity statutes constrain the answer first, and philosophy gets its turn second: many states restrict professional-entity ownership to physicians, some permit minority ownership by nurse practitioners or physician assistants, and the practice’s entity type decides what is even possible. Where a management services organization exists, ownership in that entity is frequently lawful where clinical-entity ownership is not. Whatever the answer, the clinical FTE thresholds for acquiring and retaining any equity tier apply uniformly, and counsel confirms what the practice’s own state permits before a retreat debates it. What this question must never become is a drift of side deals between individual physicians and the clinicians they informally sponsor.
Two procedural details close the gap that produced the coffee conversation. Set out the process itself—who may nominate, what documentation the candidate receives, how much notice precedes the vote, and how the vote is recorded—so that admission is an event with a file rather than a consensus that formed somewhere. And decide in advance what happens if a conditional offer is declined by the partners after it has been extended: what the candidate is told, what the practice owes her, and whether her employment continues. Nothing damages a group faster than an offer half-made and then withdrawn by silence.
Red flags. A new partner admitted by managing-partner decision alone. No defined criteria, so admission turns on partnership popularity. A buy-in amount negotiated case by case with no formula behind it. No analysis of what the admission does to every existing voting threshold—a two-thirds rule means something different at four partners than at three. And advanced practice provider eligibility assumed rather than addressed.
The practice that runs this well makes it look effortless. One rural pediatrician, after buying out her deadlocked partner, commissioned the agreement her next partnership would deserve. Three years later, when her associate made partner, the admission took one meeting and no attorneys’ conference calls. The young physician’s comment is the best advertisement the effort will ever get: “I signed because I could understand it.” Admitting a new partner without a process is not growth. It is improvisation with high stakes.
Admission belongs on the reserved-matters catalog at a supermajority of two-thirds to 75 percent, decided at a noticed meeting with the terms in front of every partner in advance. Reversibility sets voting thresholds, and admission adds a person with a vote, a claim on distributions, and a buyout obligation the practice will carry for decades.
A defensible track states two to three years, but the sharpest criterion gates the offer on recovered investment rather than tenure: two to three years plus $150,000 to $300,000 of cumulative profit the associate has generated, with $200,000 the working floor most groups settle on. The stated track should be audited against the practice's own promotion history.
State corporate-practice and professional-entity statutes answer first. Many states restrict professional-entity ownership to physicians, some permit minority ownership by nurse practitioners or physician assistants, and the practice's entity type decides what is possible. Where a management services organization exists, ownership there is frequently lawful where clinical-entity ownership is not.
The Partnership Agreement Analyzer scores an existing agreement against the framework this series is built on — or schedule a discovery call to work through it with PMI. The full framework, with the arithmetic, lives in the textbook Pediatric Practice Management: The Fundamentals.